Already in 2013, the genome of the clear cell RCC was identified [268], which is characterized by the absence or mutation of the VHL tumour suppressor gene (localized at 3p25) and frequent inactivation of the chromatin-modifying genes PBRM1, BAP1 and SETD2 [269,270]. The gene discussed is SETD2; the disease is neoplasm.